Effect of Hyponatremia in Small Cell Lung Cancer

Ankara City Hospital Bilkent466 enrolled

Overview

In this retrospective study, the investigators determined the frequency of hyponatremia in small cell lung cancer and the prognosis. 126 (27%) of 466 patients were hyponatremic. Hyponatremia could not be corrected in 50.8% (n=64) of hyponatremic patients. Survival was found to be better in the group of whom hyponatremia was corrected.

Study Type

OBSERVATIONAL

Enrollment

466

Conditions

Small Cell Lung Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Patients diagnosed with SCLC between January 2012 and January 2017 in our hospital were retrospectively screened Exclusion Criteria: Over 18 age If data doesn't exist

Outcomes

Primary Outcomes

Mortality

Effect of hyponatremia according to mortality

Time frame: Through study completion, an average of 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.